| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3342190 | Autoimmunity Reviews | 2009 | 5 Pages |
Abstract
Systemic lupus erythematosus (SLE) has long been recognized to be characterized by dysregulated signaling pathways in T and B lymphocytes, beginning with observations of cellular hyperactivity and hyperresponsiveness, and evolving to recent studies focused upon the genetic and molecular bases of such phenomena. This review focuses on recently elucidated signaling abnormalities currently thought to be intrinsic to T and/or B cells in human SLE.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Stanford L. Peng,